Testing a new drug for advanced melanoma after other treatments stop working
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug (BT02) for advanced melanoma that has stopped responding to earlier treatments. The goal is to see if it is safe and may help shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of skin cancer called melanoma that has spread or can't be removed with surgery (but not uveal melanoma).
- You have already tried at least one treatment for your melanoma that didn't work.
- You can still take care of yourself (ECOG score 0-1) and are expected to live at least 3 more months.
- You have at least one tumor outside the brain that can be measured.
- You don't have serious heart, lung, or other health problems, and you haven't had certain treatments recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
This trial tests an experimental drug called KM602 for people with advanced solid tumors that have stopped responding to standard treatments, particularly melanoma and non-small cell lung cancer. It aims to see if the drug is safe and effective in shrinking or controlling tumors.
This Phase 1 trial studies a new experimental immunotherapy (MBS8) for people with advanced solid tumors, focusing first on safety and early signs of benefit. Depending on your cancer type and past treatments, you may receive MBS8 alone or combined with pembrolizumab.
This trial tests a new drug, LBL-024, either by itself or combined with another drug (LBL-007 or toripalimab) in people with advanced melanoma. The goal is to see if these combinations can shrink tumors or slow cancer growth.
This trial tests a new drug called LM103 for people with advanced melanoma who have already tried several standard treatments, including immunotherapy. The goal is to see if LM103 can help shrink tumors when other treatments have stopped working.
This trial tests a new medicine called BNT326, alone or with another drug BNT327, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and might help shrink tumors.
Hear when a new Advanced Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.